Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting - Exagen (NASDAQ:XGN)
SAN DIEGO, California, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, announced today the acceptance of five abstracts at the 2023 American College of
Source: benzinga.com